
STOK
USDStoke Therapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$25.000
Kõrge
$25.550
Madal
$24.660
Maht
0.81M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
1.4B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
1.17M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Tehisintellekti analüüsiaruanne
Viimati uuendatud: 30. okt 2025Stoke Therapeutics (STOK): Riding Wave of Biotech Optimism, But Risks Lurk
Price Action: Volatility With Clear Upside Momentum
The stock has swung between $12.40 and $38.69 over the past 90 days, reflecting high sensitivity to news. Key patterns:
- Explosive breakout in October (up 34% from $20.68 to $27.31 in 4 days, then a dramatic spike to $38.69 on Oct 16)
- Recent correction (-4.3% from Oct 22 to 29) followed by a small rebound on Oct 30 (closing at $31.66 vs. $31.41 open)
- Volume surged to 4x average during the October rally, showing strong institutional interest
News Impact: Positive Clinical Data Drives Surge
Three catalysts fueled the October rally:
Seotud uudised
BTIG Reiterates Buy on Stoke Therapeutics, Maintains $39 Price Target
BTIG analyst Thomas Shrader reiterates Stoke Therapeutics with a Buy and maintains $39 price target.
JP Morgan Maintains Neutral on Stoke Therapeutics, Raises Price Target to $25
JP Morgan analyst Jessica Fye maintains Stoke Therapeutics with a Neutral and raises the price target from $15 to $25.
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates
Stoke Therapeutics, Inc. (NASDAQ:STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in
Tehisintellekti ennustusBeta
Tehisintellekti soovitus
Uuendatud kell: 5. nov 2025, 09:53
69.8% Kindlus
Risk ja kauplemine
Sisenemispunkt
$29.88
Võta kasum
$32.14
Peata kahjum
$27.01
Põhitegurid
Seotud aktsiad
KREF
KKR Real Estate Finance Trust Inc.
NOM
Nuveen Missouri Quality Municipal Income Fund
OGS
ONE Gas Inc.
DLY
DoubleLine Yield Opportunities Fund Common Shares of Beneficial Interest
BNAI
Brand Engagement Network Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.